These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Heterozygous Actg2 Cai H; Xiao Y; Chen S; Lu Y; Du J; You Y; Zhu J; Zhou J; Cai W; Wang Y Neurogastroenterol Motil; 2023 Jan; 35(1):e14472. PubMed ID: 36264152 [TBL] [Abstract][Full Text] [Related]
23. Histopathological, Ultrastructural, and Immunohistochemical Findings in Kapur RP Pediatr Dev Pathol; 2023; 26(1):39-51. PubMed ID: 36571289 [TBL] [Abstract][Full Text] [Related]
24. Variants of the ACTG2 gene correlate with degree of severity and presence of megacystis in chronic intestinal pseudo-obstruction. Matera I; Rusmini M; Guo Y; Lerone M; Li J; Zhang J; Di Duca M; Nozza P; Mosconi M; Pini Prato A; Martucciello G; Barabino A; Morandi F; De Giorgio R; Stanghellini V; Ravazzolo R; Devoto M; Hakonarson H; Ceccherini I Eur J Hum Genet; 2016 Aug; 24(8):1211-5. PubMed ID: 26813947 [TBL] [Abstract][Full Text] [Related]
25. Mutation in Actin γ-2 Responsible for Megacystis Microcolon Intestinal Hypoperistalsis Syndrome in 4 Chinese Patients. Lu W; Xiao Y; Huang J; Tao Y; Yan W; Lu L; Cao Y; Cai W J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):624-626. PubMed ID: 27007401 [TBL] [Abstract][Full Text] [Related]
26. Variants in the Enteric Smooth Muscle Actin γ-2 Cause Pediatric Intestinal Pseudo-obstruction in Chinese Patients. Wei Z; Lu L; Zheng Y; Yan W; Tao Y; Xiao Y; Cai W; Wang Y J Pediatr Gastroenterol Nutr; 2021 Jan; 72(1):36-42. PubMed ID: 32810037 [TBL] [Abstract][Full Text] [Related]
27. Diagnosis of Chronic Intestinal Pseudo-obstruction and Megacystis by Sequencing the ACTG2 Gene. Milunsky A; Baldwin C; Zhang X; Primack D; Curnow A; Milunsky J J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):384-387. PubMed ID: 28422808 [TBL] [Abstract][Full Text] [Related]
29. Patient's dermal fibroblasts as disease markers for visceral myopathy. Viti F; Pramotton FM; Martufi M; Magrassi R; Pedemonte N; Nizzari M; Zanacchi FC; De Michele B; Alampi M; Zambito M; Santamaria G; Bajetto A; Sardar S; Tomati V; Gandullia P; Giampietro C; Florio T; Beltrame F; Vassalli M; Ceccherini I Biomater Adv; 2023 May; 148():213355. PubMed ID: 36893487 [TBL] [Abstract][Full Text] [Related]
30. Hahn JW; Moon SY; Kim MS; Woo MH; Sohn MJ; Kim HY; Seong MW; Park SS; Park SH; Moon JS; Ko JS J Neurogastroenterol Motil; 2022 Jan; 28(1):104-110. PubMed ID: 34980693 [TBL] [Abstract][Full Text] [Related]
31. Visceral smooth muscle α-actin deficiency associated with chronic intestinal pseudo-obstruction in a Bengal cat (Felis catus x Prionailurus bengalensis). Imai DM; Miller JL; Leonard BC; Bach J; Drees R; Steinberg H; Teixeira LB Vet Pathol; 2014 May; 51(3):612-8. PubMed ID: 23774747 [TBL] [Abstract][Full Text] [Related]
32. Clinical and genetic differences in total colonic aganglionosis in Hirschsprung's disease. Moore SW; Zaahl M J Pediatr Surg; 2009 Oct; 44(10):1899-903. PubMed ID: 19853744 [TBL] [Abstract][Full Text] [Related]
33. Oral Pyridostigmine-responsive Visceral Myopathy With ACTG2 Mutations: A Case Series. Lee H; Park S; Oh JT; Kim HM; Kim S; Lee JS J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):e16-e17. PubMed ID: 30334933 [No Abstract] [Full Text] [Related]
34. Degenerative leiomyopathy in African children: a review of current perspectives. Kaschula RO; Moore SW; Rode H; Cywes S East Afr Med J; 1993 Apr; 70(4 Suppl):37-9. PubMed ID: 8223309 [TBL] [Abstract][Full Text] [Related]
35. The Diverse Phenotype of Intestinal Dysmotility Secondary to ACTG2-related Disorders. Sandy NS; Huysentruyt K; Mulder DJ; Warner N; Chong K; Morel C; AlQahtani S; Wales PW; Martin MG; Muise AM; Avitzur Y J Pediatr Gastroenterol Nutr; 2022 May; 74(5):575-581. PubMed ID: 35149643 [TBL] [Abstract][Full Text] [Related]
36. Degenerative leiomyopathy with massive megacolon. Myopathic form of chronic idiopathic intestinal pseudo-obstruction occurring in indigenous Africans. Kaschula RO; Cywes S; Katz A; Louw JH Perspect Pediatr Pathol; 1987; 11():193-213. PubMed ID: 3601631 [No Abstract] [Full Text] [Related]
37. Familial visceral myopathies: from symptom-based syndromes to actin-related diseases. Rubenstein PA; Mayer EA Gastroenterology; 2012 Dec; 143(6):1420-3. PubMed ID: 23085350 [No Abstract] [Full Text] [Related]
38. Loss-of-function variants within LMOD1 actin-binding site 2 cause pediatric intestinal pseudo-obstruction by impairing protein stability and actin nucleation. Liu K; Lu L; Chen S; Gu B; Cai H; Wang Y; Cai W FASEB J; 2022 Mar; 36(3):e22194. PubMed ID: 35170814 [TBL] [Abstract][Full Text] [Related]
39. Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy. Nowak KJ; Wattanasirichaigoon D; Goebel HH; Wilce M; Pelin K; Donner K; Jacob RL; Hübner C; Oexle K; Anderson JR; Verity CM; North KN; Iannaccone ST; Müller CR; Nürnberg P; Muntoni F; Sewry C; Hughes I; Sutphen R; Lacson AG; Swoboda KJ; Vigneron J; Wallgren-Pettersson C; Beggs AH; Laing NG Nat Genet; 1999 Oct; 23(2):208-12. PubMed ID: 10508519 [TBL] [Abstract][Full Text] [Related]
40. Visceral myopathy: clinical syndromes, genetics, pathophysiology, and fall of the cytoskeleton. Hashmi SK; Ceron RH; Heuckeroth RO Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G919-G935. PubMed ID: 33729000 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]